NCT06590402View on ClinicalTrials.gov

Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

January 31, 2028

Conditions
Anterior Cruciate Ligament ReconstructionMedial Patellofemoral Ligament Reconstruction
Interventions
DRUG

Bupivacaine, Dexamethasone in Adductor Canal Block

0.25% 15-20ml bupivacaine (local anesthestic) delivered as part of the adductor canal block with 2 mg preservative-free dexamethasone (corticosteroid) delivered as part of the adductor canal block

DRUG

Bupivacaine, Dexamethasone in Anterior Femoral Cutaneous Nerve Block

10 ml of 0.25% bupivacaine (local anesthetic) delivered as part of the anterior femoral cutaneous nerve block with 2 mg preservative-free dexamethasone (corticosteroid) delivered as part of the anterior femoral cutaneous nerve block

Trial Locations (1)

10021

RECRUITING

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER